The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia

1. Prades, R.
2. Munarriz-Cuezva, E.
3. Urigüen, L.
4. Gil-Pisa, I.
5. Gómez, L.
6. Mendieta, L.
7. Royo, S.
8. Giralt, E.
9. Tarragó, T.
10. Meana, J.J.